
2 Army Hospital neonatologists come with book on newborn care
'Care of Newborn Baby, a Handy Guide" by Dr Shankar Narayan and Dr Subhash Chandra Shaw was released by NITI Aayog member Dr Vinod Paul on Thursday.
With the social structure of our times being dominated by nuclear families, most parents of newborn babies do not have the comfort of elders being physically around to participate in caring for the baby, Shaw said.
Changing circumstances like most couples working also contributes to anxiety about appropriate care being provided to their baby, he said.
'The situation is compounded by the availability of a wide variety of information on newborns which may not all be correct or appropriate," Shaw said.
'This book is thus a small effort to try and bridge this gap in the right kind of knowledge that would help parents provide appropriate care confidently for their newborn baby," he stated.
To arrive at the material in this book, published by National Book Trust, the authors have selected questions most often asked by parents of newborn babies, those encountered in OPDs and post natal wards, and tried to provide appropriate answers to these very questions. PTI PLB ZMN
(This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments
First Published:
August 08, 2025, 22:15 IST
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


News18
an hour ago
- News18
Lupin launches generic medication in US
Agency: PTI Last Updated: New Delhi, Aug 11 (PTI) Drug maker Lupin on Monday said it has launched a medication, used to regulate blood glucose levels, in the US market. The company has launched Glucagon for Injection USP, 1mg/vial packaged in an emergency kit in the US, the Mumbai-based drug maker said in a statement. The company's product is bioequivalent to Eli Lilly and company's Glucagon for Injection, 1 mg/vial, it added. Glucagon is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus and as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. As per IQVIA MAT June data, Glucagon for Injection USP, 1mg/vial packaged in an emergency kit had an estimated annual sale of USD 122 million in the US. PTI MSS DRR DRR First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.


News18
2 hours ago
- News18
Zydus Lifesciences gets USFDA approval for angina, high blood pressure drug
New Delhi, Aug 11 (PTI) Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a drug used to treat angina and high blood pressure. The company has received final approval from the US Food and Drug Administration (USFDA) for Diltiazem Hydrochloride tablets in strengths of 30 mg, 60 mg, 90 mg, and 120 mg, the drug maker said in a statement. Diltiazem Hydrochloride Tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. It belongs to a class of drugs called calcium-channel blockers. Diltiazem works by relaxing blood vessels, which reduces the workload on the heart and increases blood and oxygen supply to the heart muscle. As per IQVIA MAT June 2025 data, Diltiazem Hydrochloride Tablets had annual sales of USD 13.9 million in the US. PTI MSS DRR view comments First Published: August 11, 2025, 13:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.


Time of India
11 hours ago
- Time of India
Meghalaya: IDSP issues advisory asking people to get hospital treatment at first sign of GBS
Shillong: The Integrated Disease Surveillance Programme (IDSP) in Meghalaya has issued an advisory, urging people to immediately get treated at hospitals at the first sign of Guillain-Barre Syndrome (GBS) to tackle any potential outbreak. The advisory was issued on Friday night after GBS was detected in Pune recently. GBS is a rare neurological disorder in which the immune system attacks the peripheral nerves, often after infections such as respiratory illnesses, gastroenteritis, dengue or Zika virus. Early symptoms include weakness, tingling or numbness starting in the legs, difficulty walking or climbing stairs, loss of balance or coordination, and in severe cases, trouble breathing, swallowing or speaking -- which require urgent medical care. The advisory recommends avoiding self-medication, maintaining hygiene, steering clear of contaminated or raw food, protection against mosquito bites in dengue or Zika-prone areas, and eating nutritious food to strengthen immunity. The recent GBS outbreak in Pune, Maharashtra, has heightened concerns among public health authorities at both the state and central levels. Officials have called on the public to remain vigilant, adopt preventive measures and ensure timely medical intervention. PTI